PMID- 35187382 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220223 IS - 2472-1972 (Electronic) IS - 2472-1972 (Linking) VI - 6 IP - 3 DP - 2022 Mar 1 TI - Coexistence of Renin-independent Aldosterone Secretion and Multiple Endocrine Neoplasia Type 1 Within a Family. PG - bvac009 LID - 10.1210/jendso/bvac009 [doi] LID - bvac009 AB - Primary aldosteronism (PA) is a state of renin-independent aldosterone secretion that can range from subclinical to overt. Some normotensive individuals for whom PA screening is not routinely recommended are reported to fulfill the loading test criterion used for the diagnosis of PA. Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by the development of various endocrine tumors. Cases of PA associated with MEN1 have been reported; however, there has been no previous report on renin-independent aldosterone secretion within a family with MEN1. Herein, we present the case of a normotensive family presenting with both MEN1 and renin-independent aldosterone secretion. A 49-year-old man was admitted to our hospital for PA evaluation owing to the plasma aldosterone concentration/plasma renin activity ratio being greater than the screening cut-off value; the patient was normotensive. The patient had a history of left nephrectomy and adrenalectomy for left renal carcinoma and adrenal tumor at the age of 39 years. Subsequently, he was diagnosed with MEN1 concurrent with primary hyperparathyroidism, insulinoma, and novel MEN1 gene mutations (c.655-5_655-4insC and c.818delC). The loading tests for PA confirmation, including saline infusion, and furosemide upright and captopril challenge tests, yielded positive findings, confirming a case of renin-independent aldosterone secretion. The patient's mother, brother, and sister were also genetically or clinically diagnosed with MEN1. All of them were also normotensive and confirmed to have renin-independent aldosterone secretion. The coexistence of renin-independent aldosterone secretion and MEN1 within this family suggests a relationship between the 2 entities. CI - (c) The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. FAU - Obata, Yoshinari AU - Obata Y AUID- ORCID: 0000-0002-3443-3635 AD - Department of Diabetes and Endocrinology, Osaka Police Hospital, Osaka, Japan. FAU - Takayama, Kana AU - Takayama K AD - Department of Diabetes and Endocrinology, Osaka Police Hospital, Osaka, Japan. FAU - Maruo, Yumiko AU - Maruo Y AD - Department of Diabetes and Endocrinology, Osaka Police Hospital, Osaka, Japan. FAU - Yamaguchi, Hiroki AU - Yamaguchi H AD - Department of Diabetes and Endocrinology, Osaka Police Hospital, Osaka, Japan. FAU - Fujii, Kohei AU - Fujii K AD - Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan. FAU - Hata, Sonyun AU - Hata S AD - Diabetes Center, National Hospital Organization Osaka Medical Center, Osaka, Japan. FAU - Togawa, Yuri AU - Togawa Y AD - Department of Internal Medicine, Japan Community Healthcare Organization, Osaka Hospital, Osaka, Japan. FAU - Sanda, Azusa AU - Sanda A AD - Department of Internal Medicine, Japan Community Healthcare Organization, Osaka Hospital, Osaka, Japan. FAU - Kosugi, Motohiro AU - Kosugi M AD - Department of Diabetes and Endocrinology, Osaka Police Hospital, Osaka, Japan. FAU - Hazama, Yoji AU - Hazama Y AD - Department of Diabetes and Endocrinology, Osaka Police Hospital, Osaka, Japan. FAU - Yasuda, Tetsuyuki AU - Yasuda T AUID- ORCID: 0000-0002-1128-8834 AD - Department of Diabetes and Endocrinology, Osaka Police Hospital, Osaka, Japan. LA - eng PT - Case Reports DEP - 20220129 PL - United States TA - J Endocr Soc JT - Journal of the Endocrine Society JID - 101697997 PMC - PMC8852679 OTO - NOTNLM OT - independent aldosterone secretion OT - multiple endocrine neoplasia type 1 OT - renin EDAT- 2022/02/22 06:00 MHDA- 2022/02/22 06:01 PMCR- 2022/01/29 CRDT- 2022/02/21 06:06 PHST- 2021/07/09 00:00 [received] PHST- 2022/02/21 06:06 [entrez] PHST- 2022/02/22 06:00 [pubmed] PHST- 2022/02/22 06:01 [medline] PHST- 2022/01/29 00:00 [pmc-release] AID - bvac009 [pii] AID - 10.1210/jendso/bvac009 [doi] PST - epublish SO - J Endocr Soc. 2022 Jan 29;6(3):bvac009. doi: 10.1210/jendso/bvac009. eCollection 2022 Mar 1.